Free Trial
Emily Bodnar

Emily Bodnar Analyst Performance

Biotech Equity Research Analyst at HC Wainwright

Emily Bodnar is a stock analyst at HC Wainwright in the healthcare sector, covering 35 publicly traded companies. Over the past year, Emily Bodnar has issued 78 stock ratings, including strong buy, buy, and hold recommendations. While full access to Emily Bodnar's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Emily Bodnar's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
142 Last 1 Years
Buy Recommendations
92.20% 130 Buy Ratings
Companies Covered
35 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.7%1 ratings
Buy91.5%129 ratings
Hold7.8%11 ratings
Sell0.0%0 ratings

Out of 141 total stock ratings issued by Emily Bodnar at HC Wainwright, the majority (91.5%) have been Buy recommendations, followed by 7.8% Hold and 0.7% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
97.1% of companies on NASDAQ
34 companies
NYSE
2.9% of companies on NYSE
1 company

Emily Bodnar, an analyst at HC Wainwright, currently covers 35 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
35 companies
100.0%

Emily Bodnar of HC Wainwright specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
32 companies
91.4%
HEALTHCARE EQUIPMENT & SUPPLIES
2 companies
5.7%
PHARMACEUTICALS
1 company
2.9%

About Emily Bodnar

Emily Bodnar is a Vice President of Equity Research at H.C. Wainwright who joined the firm in January 2022. Ms. Bodnar’s research focuses on the Biotechnology and Women’s Healthcare industries. Prior to joining H.C. Wainwright, Ms. Bodnar was a Senior Equity Research Associate at Cantor Fitzgerald assisting in coverage of small/mid and large-cap biotechnology companies. Ms. Bodnar also worked as an Equity Research Associate at Berenberg Capital Markets assisting in coverage of small/mid-cap biotechnology companies. Ms. Bodnar graduated summa cum laude from Binghamton University where she received a Bachelor of Science. Ms. Bodnar has also taken several Biology and Immunology courses from Johns Hopkins University and Rice University.
Follow on LinkedIn

Emily Bodnar's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
10/2/2026Reiterated Rating$6.79Buy
TRAX
First Tracks Biotherapeutics
9/3/2026Reiterated Rating$45.28$57.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
9/1/2026Reiterated Rating$54.66$78.00Buy
ODTX
Odyssey Therapeutics
8/27/2026Initiated Coverage$25.62$44.00Buy
ODTX
Odyssey Therapeutics
8/27/2026Initiated Coverage$25.98$44.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
8/13/2026Reiterated Rating$8.17Buy
TRAX
First Tracks Biotherapeutics
8/13/2026Boost Price Target$46.13$57.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/11/2026Lower Price Target$11.94$36.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
8/11/2026Lower Price Target$2.46$14.00Buy
Agenus Inc. stock logo
AGEN
Agenus
8/11/2026Reiterated Rating$7.00$25.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
8/11/2026Boost Price Target$51.32$60.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
8/6/2026Lower Price Target$34.06$42.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
8/4/2026Reiterated Rating$46.17$78.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
8/3/2026Reiterated Rating$1.90$10.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
7/30/2026Boost Price Target$33.02$55.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
7/24/2026Set Price Target$19.42$32.00
NovoCure Limited stock logo
NVCR
NovoCure
7/23/2026Boost Price Target$19.79$52.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
7/21/2026Lower Price Target$37.10$52.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
7/20/2026Boost Price Target$27.46$45.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
7/13/2026Boost Price Target$38.03$52.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
7/13/2026Boost Price Target$57.12$77.00Buy
Agenus Inc. stock logo
AGEN
Agenus
7/13/2026Boost Price Target$6.68$30.00Buy
TRAX
First Tracks Biotherapeutics
7/10/2026Boost Price Target$32.40$44.00Buy
TRAX
First Tracks Biotherapeutics
7/8/2026Reiterated Rating$19.82$30.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
7/6/2026Reiterated Rating$55.46$70.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
6/26/2026Reiterated Rating$31.42$40.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
6/18/2026Reiterated Rating$14.68$46.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
6/17/2026Initiated Coverage$25.51$40.00Buy
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
6/17/2026Initiated Coverage$26.45$40.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
6/15/2026Reiterated Rating$3.33$10.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
5/27/2026Reiterated Rating$39.76$70.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
5/22/2026Reiterated Rating$14.06Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
5/18/2026Reiterated Rating$10.48$35.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
5/14/2026Boost Price Target$1.59$10.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
5/12/2026Boost Price Target$3.60$10.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
5/8/2026Boost Price Target$11.85$35.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
5/6/2026Boost Price Target$39.69$70.00Buy
TRAX
First Tracks Biotherapeutics
4/28/2026Initiated Coverage$18.10$30.00Buy
TRAX
First Tracks Biotherapeutics
4/28/2026Upgrade$20.05$30.00Strong-Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
4/20/2026Lower Price Target$27.11$50.00Buy
The only 5 stocks that matter (Ad)

SpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO as soon as this fall. TradeSmith CEO Keith Kaplan says chasing the next hot IPO isn't necessary. His AI-driven system, built on a platform pioneered by Google, ranks every stock in the S&P 500 and narrows the list to just five names to hold each month. Backtests show the Top Five Stocks outperformed the S&P 500 by 4x in August alone.tc pixel

See the five stocks the AI system is tracking now
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
4/1/2026Reiterated Rating$10.53$35.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/30/2026Reiterated Rating$57.40$66.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/26/2026Boost Price Target$5.42$25.00Buy
Purple Biotech Ltd. Sponsored ADR stock logo
PPBT
Purple Biotech
3/13/2026Lower Price Target$4.10$30.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
3/10/2026Lower Price Target$3.84$7.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/9/2026Lower Price Target$17.25$38.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3/4/2026Lower Price Target$3.93$7.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/4/2026Boost Price Target$52.83$66.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
3/2/2026Reiterated Rating$20.36$32.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
2/26/2026Boost Price Target$13.11$49.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/23/2026Downgrade$113.84$115.00Neutral
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
2/17/2026Initiated Coverage$1.40$9.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
2/17/2026Initiated Coverage$1.51$9.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
2/12/2026Boost Price Target$10.50$47.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
2/12/2026Boost Price Target$28.71$65.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/4/2026Reiterated Rating$68.83$115.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/20/2026Downgrade$57.52$58.00Neutral
NovoCure Limited stock logo
NVCR
NovoCure
1/13/2026Lower Price Target$14.18$39.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/8/2026Downgrade$13.73$14.00Neutral
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
12/24/2025Boost Price Target$28.85$62.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
12/19/2025Reiterated Rating$34.72$47.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
12/12/2025Boost Price Target$22.39$32.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
12/11/2025Boost Price Target$30.68$45.00Buy
Acrivon Therapeutics, Inc. stock logo
ACRV
Acrivon Therapeutics
11/25/2025Reiterated Rating$2.36$19.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/24/2025Lower Price Target$39.61$51.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
11/20/2025Lower Price Target$22.34$48.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
11/18/2025Boost Price Target$19.85$36.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
11/12/2025Boost Price Target$3.65$15.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/11/2025Lower Price Target$33.98$52.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
11/7/2025Lower Price Target$4.05$9.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
11/6/2025Boost Price Target$1.13$5.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
11/5/2025Upgrade$8.09$18.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
10/30/2025Boost Price Target$12.79$42.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
10/29/2025Boost Price Target$19.89$28.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/27/2025Boost Price Target$30.11$72.00Buy
Agenus Inc. stock logo
AGEN
Agenus
10/20/2025Reiterated Rating$3.88Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
10/20/2025Reiterated Rating$9.36$28.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
10/14/2025Initiated Coverage$1.68$12.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
10/6/2025Initiated Coverage$36.71$60.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
10/6/2025Initiated Coverage$36.76$60.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
9/30/2025Boost Price Target$23.27$59.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
9/29/2025Downgrade$0.35Neutral
Agenus Inc. stock logo
AGEN
Agenus
9/10/2025Reiterated Rating$5.07$23.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
9/4/2025Reiterated Rating$35.90$56.00Buy
Agenus Inc. stock logo
AGEN
Agenus
8/28/2025Reiterated Rating$4.54$23.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
8/15/2025Upgrade$15.32$35.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
8/13/2025Reiterated Rating$14.50$36.00Buy
Femasys Inc. stock logo
FEMY
Femasys
8/11/2025Lower Price Target$16.94$160.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
8/7/2025Lower Price Target$0.70$4.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
7/22/2025Lower Price Target$2.70$9.00Buy
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
7/15/2025Downgrade$29.53$35.00Neutral
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
7/7/2025Lower Price Target$3.04$20.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
7/1/2025Reiterated Rating$5.52$36.00Buy
Femasys Inc. stock logo
FEMY
Femasys
6/25/2025Reiterated Rating$19.00$240.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
6/16/2025Reiterated Rating$66.00$115.00Buy
Femasys Inc. stock logo
FEMY
Femasys
6/11/2025Reiterated Rating$16.74$240.00Buy
Agenus Inc. stock logo
AGEN
Agenus
6/4/2025Upgrade$5.00$25.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
5/14/2025Initiated Coverage$1.80$10.00Buy
Agenus Inc. stock logo
AGEN
Agenus
5/13/2025Reiterated Rating$3.50Neutral
Femasys Inc. stock logo
FEMY
Femasys
5/9/2025Lower Price Target$23.20$240.00Buy
Agenus Inc. stock logo
AGEN
Agenus
4/30/2025Reiterated Rating$3.05Neutral
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
4/28/2025Reiterated Rating$4.91$30.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
4/24/2025Reiterated Rating$1.71$11.00Buy
Briacell Therap stock logo
BCTX
Briacell Therap
4/22/2025Reiterated Rating$48.03$320.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
4/16/2025Lower Price Target$11.14$280.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
4/9/2025Initiated Coverage$15.80$36.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
4/1/2025Reiterated Rating$1.09$12.00Buy
Genelux Corporation stock logo
GNLX
Genelux
3/31/2025Reiterated Rating$3.08$30.00Buy
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
3/31/2025Reiterated Rating$0.68$8.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/28/2025Reiterated Rating$26.70$300.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
3/27/2025Reiterated Rating$1.37$18.00Buy
Imunon, Inc. stock logo
IMNN
Imunon
3/26/2025Reiterated Rating$15.00$210.00Buy
Acrivon Therapeutics, Inc. stock logo
ACRV
Acrivon Therapeutics
3/26/2025Lower Price Target$5.39$19.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/26/2025Reiterated Rating$10.86$105.00Buy
Genelux Corporation stock logo
GNLX
Genelux
3/25/2025Reiterated Rating$3.41$30.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
3/21/2025Reiterated Rating$0.77$5.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/19/2025Reiterated Rating$4.14$30.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/19/2025Boost Price Target$31.92$300.00Buy
Agenus Inc. stock logo
AGEN
Agenus
3/18/2025Reiterated Rating$1.78Neutral
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3/18/2025Reiterated Rating$2.77$11.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
3/18/2025Reiterated Rating$8.06$35.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
3/17/2025Reiterated Rating$8.45$36.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
3/13/2025Reiterated Rating$25.34$560.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/13/2025Reiterated Rating$28.80$240.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/12/2025Reiterated Rating$11.11$105.00Buy
Agenus Inc. stock logo
AGEN
Agenus
3/12/2025Reiterated Rating$2.05Neutral
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/11/2025Reiterated Rating$4.25$30.00Buy
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
3/11/2025Reiterated Rating$5.14$40.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
3/7/2025Reiterated Rating$8.55$36.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
3/5/2025Reiterated Rating$0.91$12.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/5/2025Reiterated Rating$4.18$30.00Buy
Femasys Inc. stock logo
FEMY
Femasys
2/26/2025Reiterated Rating$31.60$240.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
2/25/2025Boost Price Target$10.65$35.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
2/24/2025Initiated Coverage$35.22$58.00Buy
Femasys Inc. stock logo
FEMY
Femasys
2/11/2025Reiterated Rating$25.10$240.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
2/6/2025Reiterated Rating$321.02$560.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
2/3/2025Reiterated Rating$1.05$18.00Buy
Briacell Therap stock logo
BCTX
Briacell Therap
2/3/2025Boost Price Target$50.80$320.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
1/30/2025Reiterated Rating$12.84$105.00Buy
Agenus Inc. stock logo
AGEN
Agenus
1/22/2025Reiterated Rating$3.83Neutral
Here’s Why Trump Won’t End The Iran War (Ad)

Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.tc pixel

Uncover the real reason Trump may never end this war
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/14/2025Reiterated Rating$1.95Neutral
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
1/10/2025Lower Price Target$6.99$40.00Buy